Robert Dagil
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.
Journal: Cell death & disease
Published: May 14, 2025
Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate.
Journal: NPJ precision oncology
Published: January 17, 2025
Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour-Derived Extracellular Vesicles.
Journal: Journal of extracellular vesicles
Published: September 06, 2024
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors.
Journal: EMBO molecular medicine
Published: May 31, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
Journal: Communications biology
Published: October 31, 2023
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
Journal: Nature communications
Published: October 09, 2023
Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 29, 2022
Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.
Journal: PLoS pathogens
Published: June 07, 2022
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
Journal: mBio
Published: October 12, 2021
Last Updated: 09/26/2026